Plume is a comprehensive virtual care provider built for the health needs of the transgender community, led by CEO Dr. Matthew Wetschler and CMO Dr. Jerrica Kirkley. Members pay $99 per month for 24/7 access to gender-affirming care, personal consultations, lab testing, facilitated support groups, medical letters of support for surgery and name and gender marker changes, and home delivery of prescriptions and gender-affirming medication as medically appropriate. The service is available to over 90% of the trans population across the United States. Plume raised $24M in a Series B financing. The company intends to use the funds to expand coverage nationwide, enter virtual primary care, and ensure Plume is covered by insurance. Plume is based in Denver, Colorado. Plume offers a subscription telehealth service for the transgender community that includes 24/7 access to gender-affirming care, personal consultations, lab monitoring, letters of support, and home delivery of hormone medications. Members pay $99 a month for the service and Plume does not require insurance. The company says it is currently available to over 90% of the trans population across the United States. Led by co-founder and CEO Dr. Matthew Wetschler and Chief Medical Officer Dr. Jerrica Kirkley, Plume focuses on increasing access to care, medication and products for trans people. The company plans to use new funding to scale growth nationally, hire top-tier talent specialized in trans health, and expand reach into new markets. Plume raised $14M in a Series A to support these initiatives. Plume offers telehealth-based gender-affirming care centered on hormone replacement therapy, medical evaluation, ongoing monitoring, lab assignments, and prescriptions. The service is offered for $99 per month and the company plans to add medication delivery soon. A majority of Plume’s care team is transgender, and the company provides consultations and referrals for surgical options (it does not perform surgeries). Plume began in Colorado a year ago and has expanded availability to California, New York, Florida, Texas, North Carolina, Virginia, Oregon, Maine and Massachusetts. The article cites population and market context: roughly 1.4 million Americans identify as transgender, about 700,000 are currently reachable by Plume’s services, and the transgender population’s medication spend is estimated at $4.5–$6 billion. Founders Matthew Wetschler and Jerrica Kirkley built the service to address discriminatory care and access gaps faced by transgender patients.

Total raised

$41M

Funding rounds

3

Latest round

Series B

Latest activity

Aug 2022